pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4667 |
Genomic Coordinates | chr9: 35608094 - 35608159 |
Description | Homo sapiens miR-4667 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4667-3p | ||||||||||||||||||||||||||||||
Sequence | 46| UCCCUCCUUCUGUCCCCACAG |66 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | VAV3 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | vav guanine nucleotide exchange factor 3 | ||||||||||||||||||||
Transcript | NM_001079874 | ||||||||||||||||||||
Other Transcripts | NM_006113 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on VAV3 | |||||||||||||||||||||
3'UTR of VAV3 (miRNA target sites are highlighted) |
>VAV3|NM_001079874|3'UTR 1 ATTCAAATCCCGTGTTGCACCCTGCACCAAAAATTTCAGAGAAGGGATAAATAGAAGCCTGCACAGCATCGTGAATTAAC 81 TGAAGTGTTTAAAAAGCTGCATTTCTGGCTGTTCAACATCCTCCCTCCTTAGCCCCTCCTAAGTCTTAATGCTGAGATTT 161 CTAAAGATGCTGGTACTGACAGATTAATGGCTTGCCTAGAGCTGTGCAAGAAACAGCCTGCCAGTCTGTCATTGTCAGGG 241 ACCAGGGCAAAACCAAGAGCTGTTCTTCCCAGAAGAGCCCTGCAAACACATTGGTTCGTGCTTCCCTTTACTTCTTCTGG 321 TCAGATACCATGAATGCCAGTCATCAGTAAATCTTAATACACTTTTGCTTTATTCTCACATGCCATTCACCAGATTATTT 401 GATGGTACAAAGAAGCAGAAGTGTAATTTTCCTTTTCCCAGCATGACGAAAAATTGGAGTTCTGCCATTTGAGCAGCTTA 481 CTGGAAAGATCCAGCCTTACTTGTCTTAAATTGTCCAACAAGGTGACTCATTGCCCGGCAAACACTTTTACCCTCAGATG 561 TTACTCATGATATTATAAAATATGAGGCCAGTGCTCAGGTTTGCATCATAAGTGAGCTATCCCTGAAGGGTTTTAATTAC 641 TTATTTGGTGTCCTGATTATATTTGCAAACTTCTTTATAAAAGGTGAAAAAAGCACACAAAAGAGAGGGTGTCTTCATAT 721 TAAACCTTCACAACCTTCATGATTTCATAGGATTATTTTGGAAATATAGCACTTGACTTTATGAAAGGATCTGGGCTAGG 801 TATATTAAGGGTAGTTGCCAATAACCTGAAGAAGCTGGCATTGTTTACAGAAACAGATCAAGGGCTATAATTTATGTCAT 881 TTTATAGCAGCAGTATCTATTAATACATGCCTTTTCCTCCCATCCACCTCCCCCGCACACACACAAAGATGACCTGGGAC 961 ATGATTTTTTTATTCCCACATTTTCTTGGAGCACAAACAACTTTGTTGAGGATTTTGGAAGGAAAGCACAACTGGGTCCT 1041 TTATTCATTTCTGGGACAGAAAGAGGGTCAGTGGACTTTTGTGGGCCTCCAGCTTCTCTCAGAGTCTCCCCCTCTGCAGC 1121 CCATCCTGGGAGTGTATTAACTGGAGGGAAGATGGGTCTTGCAGTACATTTGTTTTGCCCAGCCATCACTCTTTTTTGTG 1201 AGGAGCCTAAATACATTCTTCCTGGGGTCCAGAGTCCCCATTCAAGGCAGTCAAGTTAAGACACTAACTTGGCCCTTTCC 1281 TGATGGAAATATTTCCTCCATAGCAGAAGTTGTGTTCTGACAAGACTGAGAGAGTTACATGTTGGGAAAAAAAAGAAGCA 1361 TTAACTTAGTAGAACTGAACCAGGAGCATTAAGTTCTGAAATTTTGAATCATCTCTGAAATGAAGCAGGTGTAGCCTGCC 1441 CTCTCATCAATCCGTCTGGGTGCCAGAACTCAAGGTTCAGTGGACACATCCCCCTGTTAGAGACCCTCATGGGCTAGGAC 1521 TTTTCATCTAGGATAGATTCAAGACCTTTACCTCAGAATTATGTAAACTGTGATTGTGTTTTAGAAAAATTATTATTTGC 1601 TAAAACCATTTAAGTCTTTGTATATGTGTAAATGATCACAAAAATGTATTTTATAAAATGTTCTGTACAATAAAGTTACA 1681 CCTCAAAGTGTACTCTTGGAATGGATTCTTTCCTGTAAAGTCTTATCTGCGACTCTGTCTCGGGAATGTTTTGTCTGTTG 1761 CCGTCAGCCGAACTTTGTTATGGAGGGAGCAGCCTCACACAAGCAGAAACACTCCTGTGGATGGTATTGTAGCATGTATT 1841 GTTTATTTTAGTCAATAGACCCTCTCCTTATAAATGGTGTTTAGTCTTCCTGTTGCATTTCATGGGCCTGGGGGTTTCCT 1921 AGCAGAGGATATTGGAGCCCCTTTTTGTGACATTACCAATTACATCTTTGTCCACGTTTAATACTTTGTTTTGGAAAATT 2001 TAAATGCTGCAGATTTGTGTAGAGTTCTAATACCAAAGACAGAAGTAAATGTTTTCCATATACTTTGTCTTGCCTGTATG 2081 CAGCCCTCGTGTAATACGGTGAATTAGAGTGGTATTTCACTTTGTATTATTTTGTAAATATGTCAATATAATAAATAGTG 2161 ACTAAATTGATAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HeLa | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Chi_ControlB_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell Control B
... - Chi SW; Zang JB; Mele A; Darnell RB, 2009, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Chi SW; Zang JB; Mele A; Darnell RB - Nature, 2009
MicroRNAs (miRNAs) have critical roles in the regulation of gene expression; however, as miRNA activity requires base pairing with only 6-8 nucleotides of messenger RNA, predicting target mRNAs is a major challenge. Recently, high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) has identified functional protein-RNA interaction sites. Here we use HITS-CLIP to covalently crosslink native argonaute (Ago, also called Eif2c) protein-RNA complexes in mouse brain. This produced two simultaneous data sets-Ago-miRNA and Ago-mRNA binding sites-that were combined with bioinformatic analysis to identify interaction sites between miRNA and target mRNA. We validated genome-wide interaction maps for miR-124, and generated additional maps for the 20 most abundant miRNAs present in P13 mouse brain. Ago HITS-CLIP provides a general platform for exploring the specificity and range of miRNA action in vivo, and identifies precise sequences for targeting clinically relevant miRNA-mRNA interactions.
LinkOut: [PMID: 19536157]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 , TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
PAR-CLIP data was present in GSM1462573. RNA binding protein: AGO2. Condition:TZM-bl BaL
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293/HeLa |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1067869. RNA binding protein: AGO2. Condition:Ago2 IP-seq (asynchronous cells)
HITS-CLIP data was present in GSM1067870. RNA binding protein: AGO2. Condition:Ago2 IP-seq (mitotic cells)
... - Kishore S; Gruber AR; Jedlinski DJ; Syed et al., 2013, Genome biology. |
Article |
- Kishore S; Gruber AR; Jedlinski DJ; Syed et al. - Genome biology, 2013
BACKGROUND: In recent years, a variety of small RNAs derived from other RNAs with well-known functions such as tRNAs and snoRNAs, have been identified. The functional relevance of these RNAs is largely unknown. To gain insight into the complexity of snoRNA processing and the functional relevance of snoRNA-derived small RNAs, we sequence long and short RNAs, small RNAs that co-precipitate with the Argonaute 2 protein and RNA fragments obtained in photoreactive nucleotide-enhanced crosslinking and immunoprecipitation (PAR-CLIP) of core snoRNA-associated proteins. RESULTS: Analysis of these data sets reveals that many loci in the human genome reproducibly give rise to C/D box-like snoRNAs, whose expression and evolutionary conservation are typically less pronounced relative to the snoRNAs that are currently cataloged. We further find that virtually all C/D box snoRNAs are specifically processed inside the regions of terminal complementarity, retaining in the mature form only 4-5 nucleotides upstream of the C box and 2-5 nucleotides downstream of the D box. Sequencing of the total and Argonaute 2-associated populations of small RNAs reveals that despite their cellular abundance, C/D box-derived small RNAs are not efficiently incorporated into the Ago2 protein. CONCLUSIONS: We conclude that the human genome encodes a large number of snoRNAs that are processed along the canonical pathway and expressed at relatively low levels. Generation of snoRNA-derived processing products with alternative, particularly miRNA-like, functions appears to be uncommon.
LinkOut: [PMID: 23706177]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177602. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_4
PAR-CLIP data was present in ERX177609. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_11
PAR-CLIP data was present in ERX177610. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_12
PAR-CLIP data was present in ERX177614. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_4
PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8
PAR-CLIP data was present in ERX177622. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_12
PAR-CLIP data was present in ERX177633. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_11
PAR-CLIP data was present in ERX177634. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_12
PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5
PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5
PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7
PAR-CLIP data was present in ERX177608. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_2_10
PAR-CLIP data was present in ERX177620. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_10
PAR-CLIP data was present in ERX177629. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_7
PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8
PAR-CLIP data was present in ERX177632. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_10
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
PAR-CLIP data was present in ERX177607. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_9
PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5
PAR-CLIP data was present in ERX177619. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_9
PAR-CLIP data was present in ERX177631. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_9
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
Experimental Support 6 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760618. RNA binding protein: AGO2. Condition:AGO-CLIP-PC3_B
PAR-CLIP data was present in SRX1760631. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_B
PAR-CLIP data was present in SRX1760620. RNA binding protein: AGO2. Condition:AGO-CLIP-LAPC4_A
PAR-CLIP data was present in SRX1760628. RNA binding protein: AGO2. Condition:AGO-CLIP-LAPC4_B
PAR-CLIP data was present in SRX1760638. RNA binding protein: AGO2. Condition:AGO-CLIP-PC3-miR148
PAR-CLIP data was present in SRX1760639. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_A
PAR-CLIP data was present in SRX1760641. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_B
PAR-CLIP data was present in SRX1760630. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_A
PAR-CLIP data was present in SRX1760583. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_A
PAR-CLIP data was present in SRX1760591. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_B
PAR-CLIP data was present in SRX1760632. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset Chi_ControlB_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell Control B |
Location of target site | ENST00000370056.4 | 3UTR | CUAGUAGGAGGGCCGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1067869 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293/HeLa / Ago2 IP-seq (asynchronous cells) |
Location of target site | ENST00000370056.4 | 3UTR | UAGUAGGAGGGCCGCUGCGGUGAGUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23706177 / GSE43666 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1067870 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293/HeLa / Ago2 IP-seq (mitotic cells) |
Location of target site | ENST00000370056.4 | 3UTR | CUAGUAGGAGGGCCGCUGCGGUGAGUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23706177 / GSE43666 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000370056.4 | 3UTR | GUAGGAGGGCCGCUGCGGUGAGUCUUGAAGCCCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM545213 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000370056.4 | 3UTR | UAGGAGGGCCGCUGCGGUGAGUCUUGAAGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000370056.4 | 3UTR | AGUAGGAGGGCCGCUGCGGUGAGUCUUGAAGCCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000370056.4 | 3UTR | AGUAGGAGGGCCGCUGCGGUGAGUCUUGAAGCCCAGGGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1462573 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl BaL |
Location of target site | ENST00000370056.4 | 3UTR | AGUAGGAGGGCCGCUGCGGUGAGUCUUGAAGCCCAGGGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000370056.4 | 3UTR | CUAGUAGGAGGGCCGCUGCGGUGAGUCUUGAAGCCCAGGGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT256051 | UBE2K | ubiquitin conjugating enzyme E2 K | 2 | 4 | ||||||||
MIRT306046 | SKIL | SKI like proto-oncogene | 2 | 10 | ||||||||
MIRT348290 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT380488 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT441955 | MAGEB10 | MAGE family member B10 | 2 | 6 | ||||||||
MIRT447735 | MOCOS | molybdenum cofactor sulfurase | 2 | 2 | ||||||||
MIRT449260 | PALM2 | paralemmin 2 | 2 | 4 | ||||||||
MIRT456108 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 8 | ||||||||
MIRT471140 | PHF19 | PHD finger protein 19 | 2 | 4 | ||||||||
MIRT486256 | BCORL1 | BCL6 corepressor like 1 | 2 | 2 | ||||||||
MIRT489562 | PLD6 | phospholipase D family member 6 | 2 | 2 | ||||||||
MIRT489898 | PPIC | peptidylprolyl isomerase C | 2 | 4 | ||||||||
MIRT497434 | SEC63 | SEC63 homolog, protein translocation regulator | 2 | 4 | ||||||||
MIRT499611 | DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 | 2 | 8 | ||||||||
MIRT506401 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 8 | ||||||||
MIRT513021 | NSFL1C | NSFL1 cofactor | 2 | 6 | ||||||||
MIRT513044 | BRIX1 | BRX1, biogenesis of ribosomes | 2 | 2 | ||||||||
MIRT526173 | ANKRD65 | ankyrin repeat domain 65 | 2 | 2 | ||||||||
MIRT527820 | TMEM74B | transmembrane protein 74B | 2 | 2 | ||||||||
MIRT528177 | C6orf47 | chromosome 6 open reading frame 47 | 2 | 2 | ||||||||
MIRT530306 | TNFRSF10D | TNF receptor superfamily member 10d | 2 | 2 | ||||||||
MIRT531943 | AACS | acetoacetyl-CoA synthetase | 2 | 2 | ||||||||
MIRT531987 | SLCO1B3 | solute carrier organic anion transporter family member 1B3 | 2 | 2 | ||||||||
MIRT534821 | RAB30 | RAB30, member RAS oncogene family | 2 | 2 | ||||||||
MIRT536153 | MAP4K5 | mitogen-activated protein kinase kinase kinase kinase 5 | 2 | 2 | ||||||||
MIRT540297 | TMA16 | translation machinery associated 16 homolog | 2 | 2 | ||||||||
MIRT543485 | RXRA | retinoid X receptor alpha | 2 | 2 | ||||||||
MIRT547506 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT569289 | SLC35C2 | solute carrier family 35 member C2 | 2 | 2 | ||||||||
MIRT572754 | FAM204A | family with sequence similarity 204 member A | 2 | 2 | ||||||||
MIRT575266 | Timp3 | tissue inhibitor of metalloproteinase 3 | 2 | 2 | ||||||||
MIRT609477 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT610265 | LRRC47 | leucine rich repeat containing 47 | 2 | 2 | ||||||||
MIRT610350 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT610396 | FOXE1 | forkhead box E1 | 2 | 2 | ||||||||
MIRT610492 | GPC4 | glypican 4 | 2 | 4 | ||||||||
MIRT612511 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT612760 | MYOCD | myocardin | 2 | 2 | ||||||||
MIRT613414 | CDH8 | cadherin 8 | 2 | 2 | ||||||||
MIRT613703 | QPRT | quinolinate phosphoribosyltransferase | 2 | 2 | ||||||||
MIRT613814 | ATP6AP1L | ATPase H+ transporting accessory protein 1 like | 2 | 2 | ||||||||
MIRT614170 | MYO1F | myosin IF | 2 | 2 | ||||||||
MIRT614214 | LENG9 | leukocyte receptor cluster member 9 | 2 | 2 | ||||||||
MIRT614225 | TSKU | tsukushi, small leucine rich proteoglycan | 2 | 2 | ||||||||
MIRT614497 | RHOB | ras homolog family member B | 2 | 2 | ||||||||
MIRT614986 | GIPC1 | GIPC PDZ domain containing family member 1 | 2 | 2 | ||||||||
MIRT615222 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 2 | 2 | ||||||||
MIRT615326 | ERN1 | endoplasmic reticulum to nucleus signaling 1 | 2 | 2 | ||||||||
MIRT615494 | SHB | SH2 domain containing adaptor protein B | 2 | 2 | ||||||||
MIRT615506 | CNNM3 | cyclin and CBS domain divalent metal cation transport mediator 3 | 2 | 2 | ||||||||
MIRT615536 | PHF1 | PHD finger protein 1 | 2 | 2 | ||||||||
MIRT615550 | TNFSF15 | TNF superfamily member 15 | 2 | 2 | ||||||||
MIRT615954 | SORD | sorbitol dehydrogenase | 2 | 2 | ||||||||
MIRT616478 | MACC1 | MACC1, MET transcriptional regulator | 2 | 2 | ||||||||
MIRT616667 | ST3GAL1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT616742 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT616760 | SVOP | SV2 related protein | 2 | 2 | ||||||||
MIRT616913 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT617645 | RAB43 | RAB43, member RAS oncogene family | 2 | 2 | ||||||||
MIRT617822 | EMX2 | empty spiracles homeobox 2 | 2 | 2 | ||||||||
MIRT618468 | GPR55 | G protein-coupled receptor 55 | 2 | 2 | ||||||||
MIRT618517 | SELPLG | selectin P ligand | 2 | 2 | ||||||||
MIRT618687 | DVL1 | dishevelled segment polarity protein 1 | 2 | 2 | ||||||||
MIRT619464 | XRCC2 | X-ray repair cross complementing 2 | 2 | 2 | ||||||||
MIRT619560 | GABRG2 | gamma-aminobutyric acid type A receptor gamma2 subunit | 2 | 2 | ||||||||
MIRT620004 | C1orf64 | steroid receptor associated and regulated protein | 2 | 2 | ||||||||
MIRT620210 | VN1R1 | vomeronasal 1 receptor 1 | 2 | 2 | ||||||||
MIRT620446 | SEMA3E | semaphorin 3E | 2 | 2 | ||||||||
MIRT621297 | SLC35B1 | solute carrier family 35 member B1 | 2 | 2 | ||||||||
MIRT621765 | TNFAIP3 | TNF alpha induced protein 3 | 2 | 2 | ||||||||
MIRT621812 | TMEM170B | transmembrane protein 170B | 2 | 2 | ||||||||
MIRT622171 | SMYD1 | SET and MYND domain containing 1 | 2 | 2 | ||||||||
MIRT622202 | SLC5A12 | solute carrier family 5 member 12 | 2 | 2 | ||||||||
MIRT622295 | SH3BP5L | SH3 binding domain protein 5 like | 2 | 2 | ||||||||
MIRT622718 | PLEKHA2 | pleckstrin homology domain containing A2 | 2 | 2 | ||||||||
MIRT622893 | PDCL | phosducin like | 2 | 2 | ||||||||
MIRT623215 | MTFR1L | mitochondrial fission regulator 1 like | 2 | 2 | ||||||||
MIRT623230 | MON1B | MON1 homolog B, secretory trafficking associated | 2 | 2 | ||||||||
MIRT623548 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | 2 | 2 | ||||||||
MIRT623557 | JPH3 | junctophilin 3 | 2 | 2 | ||||||||
MIRT623669 | HRK | harakiri, BCL2 interacting protein | 2 | 2 | ||||||||
MIRT623730 | GTDC1 | glycosyltransferase like domain containing 1 | 2 | 4 | ||||||||
MIRT623742 | GRIN2B | glutamate ionotropic receptor NMDA type subunit 2B | 2 | 2 | ||||||||
MIRT623906 | FOXK2 | forkhead box K2 | 2 | 2 | ||||||||
MIRT624181 | DERL2 | derlin 2 | 2 | 2 | ||||||||
MIRT625758 | GPC5 | glypican 5 | 2 | 2 | ||||||||
MIRT625975 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 2 | 2 | ||||||||
MIRT626300 | KCNK12 | potassium two pore domain channel subfamily K member 12 | 2 | 2 | ||||||||
MIRT626779 | PI4K2B | phosphatidylinositol 4-kinase type 2 beta | 2 | 2 | ||||||||
MIRT627034 | TMEM109 | transmembrane protein 109 | 2 | 4 | ||||||||
MIRT627109 | PDRG1 | p53 and DNA damage regulated 1 | 2 | 2 | ||||||||
MIRT627405 | TMEM170A | transmembrane protein 170A | 2 | 2 | ||||||||
MIRT628390 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT628428 | ARRB1 | arrestin beta 1 | 2 | 2 | ||||||||
MIRT629824 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT630870 | UBXN11 | UBX domain protein 11 | 2 | 2 | ||||||||
MIRT630968 | KIAA2022 | neurite extension and migration factor | 2 | 2 | ||||||||
MIRT631588 | ITGAL | integrin subunit alpha L | 2 | 2 | ||||||||
MIRT633209 | WFDC6 | WAP four-disulfide core domain 6 | 2 | 2 | ||||||||
MIRT635310 | FAM179A | TOG array regulator of axonemal microtubules 2 | 2 | 2 | ||||||||
MIRT637062 | PRKAG1 | protein kinase AMP-activated non-catalytic subunit gamma 1 | 2 | 2 | ||||||||
MIRT637116 | KLHL21 | kelch like family member 21 | 2 | 2 | ||||||||
MIRT637635 | ZNF431 | zinc finger protein 431 | 2 | 2 | ||||||||
MIRT638390 | RAB11FIP1 | RAB11 family interacting protein 1 | 2 | 2 | ||||||||
MIRT639178 | CEP70 | centrosomal protein 70 | 2 | 2 | ||||||||
MIRT639777 | GPR45 | G protein-coupled receptor 45 | 2 | 2 | ||||||||
MIRT639885 | STC1 | stanniocalcin 1 | 2 | 2 | ||||||||
MIRT640003 | PHF21B | PHD finger protein 21B | 2 | 2 | ||||||||
MIRT640640 | FBXL18 | F-box and leucine rich repeat protein 18 | 2 | 2 | ||||||||
MIRT640824 | GPR107 | G protein-coupled receptor 107 | 2 | 2 | ||||||||
MIRT641253 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT641434 | SCUBE3 | signal peptide, CUB domain and EGF like domain containing 3 | 2 | 2 | ||||||||
MIRT641746 | MACROD2 | MACRO domain containing 2 | 2 | 2 | ||||||||
MIRT641869 | STOML1 | stomatin like 1 | 2 | 2 | ||||||||
MIRT641890 | SND1 | staphylococcal nuclease and tudor domain containing 1 | 2 | 2 | ||||||||
MIRT642356 | C19orf40 | Fanconi anemia core complex associated protein 24 | 1 | 1 | ||||||||
MIRT644007 | PPP1R3G | protein phosphatase 1 regulatory subunit 3G | 2 | 2 | ||||||||
MIRT644301 | ZSCAN29 | zinc finger and SCAN domain containing 29 | 2 | 2 | ||||||||
MIRT645706 | C1orf50 | chromosome 1 open reading frame 50 | 2 | 2 | ||||||||
MIRT645752 | FAM213A | family with sequence similarity 213 member A | 2 | 2 | ||||||||
MIRT646123 | SLC26A9 | solute carrier family 26 member 9 | 2 | 2 | ||||||||
MIRT646397 | SLC22A6 | solute carrier family 22 member 6 | 2 | 2 | ||||||||
MIRT646490 | APBB3 | amyloid beta precursor protein binding family B member 3 | 2 | 2 | ||||||||
MIRT646576 | XPNPEP3 | X-prolyl aminopeptidase 3 | 2 | 2 | ||||||||
MIRT647151 | CYP27C1 | cytochrome P450 family 27 subfamily C member 1 | 2 | 2 | ||||||||
MIRT647554 | CYP2B6 | cytochrome P450 family 2 subfamily B member 6 | 2 | 2 | ||||||||
MIRT647761 | RNF168 | ring finger protein 168 | 2 | 2 | ||||||||
MIRT648078 | ZMIZ2 | zinc finger MIZ-type containing 2 | 2 | 2 | ||||||||
MIRT648644 | ZNF562 | zinc finger protein 562 | 2 | 2 | ||||||||
MIRT648967 | TMEM45B | transmembrane protein 45B | 2 | 2 | ||||||||
MIRT649126 | SRD5A1 | steroid 5 alpha-reductase 1 | 2 | 2 | ||||||||
MIRT649556 | FAM20B | FAM20B, glycosaminoglycan xylosylkinase | 2 | 2 | ||||||||
MIRT649644 | SAMHD1 | SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | 2 | 2 | ||||||||
MIRT649781 | MRPS27 | mitochondrial ribosomal protein S27 | 2 | 4 | ||||||||
MIRT649945 | SIT1 | signaling threshold regulating transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT649975 | TRAFD1 | TRAF-type zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT650250 | CD68 | CD68 molecule | 2 | 2 | ||||||||
MIRT650717 | KRT32 | keratin 32 | 2 | 2 | ||||||||
MIRT650979 | ZNF831 | zinc finger protein 831 | 2 | 2 | ||||||||
MIRT651049 | ZNF644 | zinc finger protein 644 | 2 | 2 | ||||||||
MIRT651120 | ZNF48 | zinc finger protein 48 | 2 | 2 | ||||||||
MIRT651221 | ZNF225 | zinc finger protein 225 | 2 | 2 | ||||||||
MIRT651277 | ZDHHC5 | zinc finger DHHC-type containing 5 | 2 | 2 | ||||||||
MIRT651401 | ZBTB16 | zinc finger and BTB domain containing 16 | 2 | 2 | ||||||||
MIRT651410 | ZADH2 | zinc binding alcohol dehydrogenase domain containing 2 | 2 | 2 | ||||||||
MIRT652198 | TRIM39 | tripartite motif containing 39 | 2 | 2 | ||||||||
MIRT652710 | THBS2 | thrombospondin 2 | 2 | 4 | ||||||||
MIRT652763 | TENM4 | teneurin transmembrane protein 4 | 2 | 2 | ||||||||
MIRT653031 | STX1B | syntaxin 1B | 2 | 2 | ||||||||
MIRT653099 | SRSF7 | serine and arginine rich splicing factor 7 | 2 | 2 | ||||||||
MIRT653354 | SMG7 | SMG7, nonsense mediated mRNA decay factor | 2 | 2 | ||||||||
MIRT653366 | SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 2 | 2 | ||||||||
MIRT653755 | SLC12A5 | solute carrier family 12 member 5 | 2 | 2 | ||||||||
MIRT653864 | SHANK2 | SH3 and multiple ankyrin repeat domains 2 | 2 | 2 | ||||||||
MIRT653961 | SEPN1 | selenoprotein N | 2 | 2 | ||||||||
MIRT654463 | RAP2B | RAP2B, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT654483 | RANBP2 | RAN binding protein 2 | 2 | 2 | ||||||||
MIRT654696 | PSMB5 | proteasome subunit beta 5 | 2 | 2 | ||||||||
MIRT655075 | PIP4K2B | phosphatidylinositol-5-phosphate 4-kinase type 2 beta | 2 | 2 | ||||||||
MIRT655443 | PALM2-AKAP2 | PALM2-AKAP2 readthrough | 2 | 2 | ||||||||
MIRT655606 | ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | 2 | 2 | ||||||||
MIRT656026 | MYO5A | myosin VA | 2 | 4 | ||||||||
MIRT656038 | MYO10 | myosin X | 2 | 2 | ||||||||
MIRT656304 | METTL1 | methyltransferase like 1 | 2 | 2 | ||||||||
MIRT656372 | MDFI | MyoD family inhibitor | 2 | 4 | ||||||||
MIRT656399 | MCU | mitochondrial calcium uniporter | 2 | 2 | ||||||||
MIRT656415 | MCTP1 | multiple C2 and transmembrane domain containing 1 | 2 | 2 | ||||||||
MIRT656762 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT656905 | KIAA1958 | KIAA1958 | 2 | 2 | ||||||||
MIRT658938 | DPY19L1 | dpy-19 like C-mannosyltransferase 1 | 2 | 2 | ||||||||
MIRT659221 | CXXC5 | CXXC finger protein 5 | 2 | 2 | ||||||||
MIRT659281 | CTIF | cap binding complex dependent translation initiation factor | 2 | 2 | ||||||||
MIRT659483 | CLDN1 | claudin 1 | 2 | 2 | ||||||||
MIRT660112 | BTBD3 | BTB domain containing 3 | 2 | 2 | ||||||||
MIRT660305 | BHLHE40 | basic helix-loop-helix family member e40 | 2 | 2 | ||||||||
MIRT660334 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT660788 | AKAP2 | A-kinase anchoring protein 2 | 2 | 2 | ||||||||
MIRT661578 | EPHX2 | epoxide hydrolase 2 | 2 | 2 | ||||||||
MIRT661744 | DTHD1 | death domain containing 1 | 2 | 2 | ||||||||
MIRT661873 | PDLIM5 | PDZ and LIM domain 5 | 2 | 2 | ||||||||
MIRT662256 | C15orf52 | chromosome 15 open reading frame 52 | 2 | 2 | ||||||||
MIRT662698 | SPIRE2 | spire type actin nucleation factor 2 | 2 | 2 | ||||||||
MIRT662761 | LRRC3C | leucine rich repeat containing 3C | 2 | 2 | ||||||||
MIRT663315 | TECPR2 | tectonin beta-propeller repeat containing 2 | 2 | 2 | ||||||||
MIRT664687 | EIF2B2 | eukaryotic translation initiation factor 2B subunit beta | 2 | 4 | ||||||||
MIRT665966 | SZRD1 | SUZ RNA binding domain containing 1 | 2 | 2 | ||||||||
MIRT666057 | STK40 | serine/threonine kinase 40 | 2 | 2 | ||||||||
MIRT666875 | POMGNT1 | protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | 2 | 2 | ||||||||
MIRT667214 | NIPAL1 | NIPA like domain containing 1 | 2 | 2 | ||||||||
MIRT667285 | NAV1 | neuron navigator 1 | 2 | 2 | ||||||||
MIRT667648 | LGALSL | galectin like | 2 | 2 | ||||||||
MIRT668045 | GTPBP10 | GTP binding protein 10 | 2 | 2 | ||||||||
MIRT668155 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT668492 | ETV3 | ETS variant 3 | 2 | 2 | ||||||||
MIRT669356 | BHLHE22 | basic helix-loop-helix family member e22 | 2 | 2 | ||||||||
MIRT676486 | DSN1 | DSN1 homolog, MIS12 kinetochore complex component | 2 | 2 | ||||||||
MIRT684285 | CDK9 | cyclin dependent kinase 9 | 2 | 2 | ||||||||
MIRT686689 | TIMM10 | translocase of inner mitochondrial membrane 10 | 2 | 2 | ||||||||
MIRT691270 | GET4 | golgi to ER traffic protein 4 | 2 | 2 | ||||||||
MIRT698669 | TEF | TEF, PAR bZIP transcription factor | 2 | 2 | ||||||||
MIRT699893 | RUNX1 | runt related transcription factor 1 | 2 | 2 | ||||||||
MIRT702635 | ITGA5 | integrin subunit alpha 5 | 2 | 2 | ||||||||
MIRT708797 | KIFC3 | kinesin family member C3 | 2 | 2 | ||||||||
MIRT710950 | AMZ1 | archaelysin family metallopeptidase 1 | 2 | 2 | ||||||||
MIRT711228 | RETSAT | retinol saturase | 2 | 2 | ||||||||
MIRT711637 | PEBP1 | phosphatidylethanolamine binding protein 1 | 2 | 2 | ||||||||
MIRT711968 | APOA5 | apolipoprotein A5 | 2 | 2 | ||||||||
MIRT712078 | WDR37 | WD repeat domain 37 | 2 | 2 | ||||||||
MIRT712542 | CYB561D1 | cytochrome b561 family member D1 | 2 | 2 | ||||||||
MIRT713595 | ANKMY1 | ankyrin repeat and MYND domain containing 1 | 2 | 2 | ||||||||
MIRT713715 | PAOX | polyamine oxidase | 2 | 2 | ||||||||
MIRT714482 | TBL2 | transducin beta like 2 | 2 | 2 | ||||||||
MIRT715510 | MAPKBP1 | mitogen-activated protein kinase binding protein 1 | 2 | 2 | ||||||||
MIRT715833 | SZT2 | SZT2, KICSTOR complex subunit | 2 | 2 | ||||||||
MIRT715931 | CHD4 | chromodomain helicase DNA binding protein 4 | 2 | 2 | ||||||||
MIRT716183 | MTRNR2L1 | MT-RNR2-like 1 | 2 | 2 | ||||||||
MIRT716330 | POU5F1 | POU class 5 homeobox 1 | 2 | 2 | ||||||||
MIRT716942 | CACNB1 | calcium voltage-gated channel auxiliary subunit beta 1 | 2 | 2 | ||||||||
MIRT717337 | URM1 | ubiquitin related modifier 1 | 2 | 2 | ||||||||
MIRT718114 | CRTC1 | CREB regulated transcription coactivator 1 | 2 | 2 | ||||||||
MIRT718866 | LRSAM1 | leucine rich repeat and sterile alpha motif containing 1 | 2 | 2 | ||||||||
MIRT719456 | APBA1 | amyloid beta precursor protein binding family A member 1 | 2 | 2 | ||||||||
MIRT719989 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT720262 | FAM83F | family with sequence similarity 83 member F | 2 | 2 | ||||||||
MIRT721361 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT721370 | SEC14L6 | SEC14 like lipid binding 6 | 2 | 2 | ||||||||
MIRT721489 | LTB4R2 | leukotriene B4 receptor 2 | 2 | 2 | ||||||||
MIRT723010 | FADS1 | fatty acid desaturase 1 | 2 | 2 | ||||||||
MIRT723608 | FKRP | fukutin related protein | 2 | 2 | ||||||||
MIRT723686 | CIRH1A | UTP4, small subunit processome component | 2 | 2 | ||||||||
MIRT723972 | GPR146 | G protein-coupled receptor 146 | 2 | 2 | ||||||||
MIRT724826 | HOXB8 | homeobox B8 | 2 | 2 | ||||||||
MIRT725283 | OSTM1 | osteopetrosis associated transmembrane protein 1 | 2 | 2 | ||||||||
MIRT725437 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | 2 | 2 | ||||||||
MIRT725606 | CAPN6 | calpain 6 | 2 | 2 | ||||||||
MIRT731686 | BTK | Bruton tyrosine kinase | 3 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|